Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
104.3 USD | +0.39% | -6.89% | +4.84% |
Financials (USD)
Sales 2024 * | 4.22B | Sales 2025 * | 4.93B | Capitalization | 39.92B |
---|---|---|---|---|---|
Net income 2024 * | -2.78B | Net income 2025 * | -1.95B | EV / Sales 2024 * | 8.34 x |
Net cash position 2024 * | 4.73B | Net cash position 2025 * | 3.38B | EV / Sales 2025 * | 7.41 x |
P/E ratio 2024 * |
-14.4
x | P/E ratio 2025 * |
-20.6
x | Employees | 5,600 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.18% |
Latest transcript on Moderna, Inc.
1 day | -1.01% | ||
1 week | -6.89% | ||
Current month | +13.03% | ||
1 month | +17.98% | ||
3 months | +22.06% | ||
6 months | +0.12% | ||
Current year | +4.84% |
Managers | Title | Age | Since |
---|---|---|---|
Stéphane Bancel
CEO | Chief Executive Officer | 51 | 11-02-28 |
James Mock
DFI | Director of Finance/CFO | 47 | 22-09-05 |
Stephen Hoge
PSD | President | 48 | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Sagan
BRD | Director/Board Member | 65 | 18-05-31 |
Director/Board Member | 75 | 20-06-30 | |
Francois Nader
BRD | Director/Board Member | 67 | 19-12-10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
5.66% | 0 M€ | 0.00% | - | |
4.69% | 2 M€ | -.--% | ||
4.08% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-18 | 104.3 | +0.39% | 4,034,481 |
24-03-15 | 103.8 | +0.38% | 5,464,806 |
24-03-14 | 103.5 | -2.86% | 4,635,880 |
24-03-13 | 106.5 | -3.55% | 5,122,006 |
24-03-12 | 110.4 | -1.38% | 4,180,437 |
Delayed Quote Nasdaq, March 18, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.84% | 39.92B | |
+9.72% | 46.21B | |
+35.14% | 40.04B | |
-9.43% | 28.33B | |
+17.47% | 27.43B | |
-22.99% | 18.57B | |
+10.88% | 13.46B | |
+27.53% | 12.02B | |
-6.84% | 11.3B | |
+6.40% | 11.01B |